GlassScriptPhysician profile
Donald Richard Collins
NPI 1265452973
$5,230.14
in general payments reported to CMS, 2019-2025
20 companies · $1,051 in 2025
The $1,051 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $147 · 2021: $237 · 2022: $1,228 · 2023: $1,102 · 2024: $1,024 · 2025: $1,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,175.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $988.41 | 2022-2023 | Xeomin |
| Abbvie INC. | $644.78 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm, Botox |
| Davol INC. | $482.12 | 2019-2022 | |
| Mentor Worldwide LLC | $463.13 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Motiva USA, LLC | $440.17 | 2024-2025 | |
| Musculoskeletal Transplant Foundation INC. | $389.25 | 2023-2025 | |
| Allergan, INC. | $373.47 | 2019-2022 | |
| Axogen | $248.15 | 2019-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Access Pro Medical, LLC | $241.63 | 2025 | Matriderm |
| Integra Lifesciences Corporation | $155.69 | 2023 | Durasorb Monofilament Mesh |
| Biotissue Holdings INC. | $150.59 | 2025 | |
| Kerecis Limited | $149.84 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ethicon US, LLC | $116.42 | 2024 | Dermabond, Vistaseal, Surgicel Nu-Knit |
| Coopersurgical, INC. | $100.95 | 2020 | |
| Medtronic, INC. | $80.41 | 2024 | V-Loc 180 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $67.30 | 2022 | |
| Alafair Biosciences, INC. | $41.34 | 2024 | Versawrap |
| Revance Therapeutics, INC. | $35.29 | 2024 | Daxxify |
| Mimedx Group, INC. | $30.68 | 2025 | |
| Smith+Nephew, INC. | $30.52 | 2025 | Stravix Pl, Oasis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.